230 related articles for article (PubMed ID: 23977965)
21. Cellular and humoral immune responses against the Plasmodium vivax MSP-1₁₉ malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil.
Riccio EK; Totino PR; Pratt-Riccio LR; Ennes-Vidal V; Soares IS; Rodrigues MM; de Souza JM; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
Malar J; 2013 Sep; 12():326. PubMed ID: 24041406
[TBL] [Abstract][Full Text] [Related]
22. Antibodies to Plasmodium vivax reticulocyte binding protein 2b are associated with protection against P. vivax malaria in populations living in low malaria transmission regions of Brazil and Thailand.
He WQ; Karl S; White MT; Nguitragool W; Monteiro W; Kuehn A; Gruszczyk J; França CT; Sattabongkot J; Lacerda MVG; Tham WH; Mueller I
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007596. PubMed ID: 31425514
[TBL] [Abstract][Full Text] [Related]
23. Soluble recombinant merozoite surface antigen-142kDa of Plasmodium vivax: An improved diagnostic antigen for vivax malaria.
Mirahmadi H; Fallahi S; Seyyed Tabaei SJ
J Microbiol Methods; 2016 Apr; 123():44-50. PubMed ID: 26851675
[TBL] [Abstract][Full Text] [Related]
24. Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1.
Pandey JP; Morais CG; Fontes CJ; Braga EM
Malar J; 2010 Aug; 9():229. PubMed ID: 20696056
[TBL] [Abstract][Full Text] [Related]
25. Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians.
Nicolete VC; Frischmann S; Barbosa S; King CL; Ferreira MU
J Infect Dis; 2016 Nov; 214(10):1539-1546. PubMed ID: 27578850
[TBL] [Abstract][Full Text] [Related]
26. Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria.
He WQ; Shakri AR; Bhardwaj R; França CT; Stanisic DI; Healer J; Kiniboro B; Robinson LJ; Guillotte-Blisnick M; Huon C; Siba P; Cowman A; King CL; Tham WH; Chitnis CE; Mueller I
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0006987. PubMed ID: 30768655
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Naturally Acquired Antibody Responses to Two Variant Forms of Plasmodium vivax Apical Membrane Antigen-1 in Individuals Living in Areas of Low and Unstable Malaria Transmission of Iran.
Salavatifar M; Zakeri S; Abouie Mehrizi A; Mirkhazemi S; Dinparast Djadid N
Arch Iran Med; 2015 Dec; 18(12):834-43. PubMed ID: 26621016
[TBL] [Abstract][Full Text] [Related]
28. Unexpected high circulation of Plasmodium vivax in asymptomatic children from Kédougou, southeastern Senegal.
Niang M; Diop F; Niang O; Sadio BD; Sow A; Faye O; Diallo M; Sall AA; Perraut R; Toure-Balde A
Malar J; 2017 Dec; 16(1):497. PubMed ID: 29284488
[TBL] [Abstract][Full Text] [Related]
29. Naturally acquired antibodies to merozoite surface protein (MSP)-1(19) and cumulative exposure to Plasmodium falciparum and Plasmodium vivax in remote populations of the Amazon Basin of Brazil.
Ladeia-Andrade S; Ferreira MU; Scopel KK; Braga EM; Bastos Mda S; Wunderlich G; Coura JR
Mem Inst Oswaldo Cruz; 2007 Dec; 102(8):943-51. PubMed ID: 18209933
[TBL] [Abstract][Full Text] [Related]
30. The persistence of naturally acquired antibodies and memory B cells specific to rhoptry proteins of Plasmodium vivax in patients from areas of low malaria transmission.
Kochayoo P; Changrob S; Wangriatisak K; Lee SK; Chootong P; Han ET
Malar J; 2019 Nov; 18(1):382. PubMed ID: 31783870
[TBL] [Abstract][Full Text] [Related]
31. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
[TBL] [Abstract][Full Text] [Related]
32. Natural infections with different Plasmodium species induce antibodies reactive to a chimeric Plasmodium vivax recombinant protein.
McCaffery JN; Singh B; Nace D; Moreno A; Udhayakumar V; Rogier E
Malar J; 2021 Feb; 20(1):86. PubMed ID: 33579292
[TBL] [Abstract][Full Text] [Related]
33. Antigenicity studies in humans and immunogenicity studies in mice: an MSP1P subdomain as a candidate for malaria vaccine development.
Cheng Y; Shin EH; Lu F; Wang B; Choe J; Tsuboi T; Han ET
Microbes Infect; 2014 May; 16(5):419-28. PubMed ID: 24560875
[TBL] [Abstract][Full Text] [Related]
34. Induction and Kinetics of Complement-Fixing Antibodies Against Plasmodium vivax Merozoite Surface Protein 3α and Relationship With Immunoglobulin G Subclasses and Immunoglobulin M.
Oyong DA; Wilson DW; Barber BE; William T; Jiang J; Galinski MR; Fowkes FJI; Grigg MJ; Beeson JG; Anstey NM; Boyle MJ
J Infect Dis; 2019 Nov; 220(12):1950-1961. PubMed ID: 31419296
[TBL] [Abstract][Full Text] [Related]
35. Humoral immune responses against the malaria vaccine candidate antigen Plasmodium vivax AMA-1 and IL-4 gene polymorphisms in individuals living in an endemic area of the Brazilian Amazon.
Tomaz FM; da Cruz Furini AA; Capobianco MP; Póvoa MM; Trindade PC; Fraga VD; Conceição LM; de Azevedo LR; Oliani SM; Cassiano GC; Cavasini CE; Dos Santos SE; Machado RL
Cytokine; 2015 Aug; 74(2):273-8. PubMed ID: 25922277
[TBL] [Abstract][Full Text] [Related]
36. Malaria serology data from the Guiana shield: first insight in IgG antibody responses to Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae antigens in Suriname.
Labadie-Bracho MY; van Genderen FT; Adhin MR
Malar J; 2020 Oct; 19(1):360. PubMed ID: 33032606
[TBL] [Abstract][Full Text] [Related]
37. The influence of intestinal parasites on Plasmodium vivax-specific antibody responses to MSP-119 and AMA-1 in rural populations of the Brazilian Amazon.
Sánchez-Arcila JC; de França MM; Pereira VA; Vasconcelos MP; Têva A; Perce-da-Silva Dde S; Neto JR; Aprígio CJ; Lima-Junior Jda C; Rodrigues MM; Soares IS; Banic DM; Oliveira-Ferreira J
Malar J; 2015 Nov; 14():442. PubMed ID: 26546161
[TBL] [Abstract][Full Text] [Related]
38. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
Stanisic DI; Richards JS; McCallum FJ; Michon P; King CL; Schoepflin S; Gilson PR; Murphy VJ; Anders RF; Mueller I; Beeson JG
Infect Immun; 2009 Mar; 77(3):1165-74. PubMed ID: 19139189
[TBL] [Abstract][Full Text] [Related]
39. Plasmodium falciparum merozoite surface protein 1 (MSP1): genotyping and humoral responses to allele-specific variants.
Ekala MT; Jouin H; Lekoulou F; Issifou S; Mercereau-Puijalon O; Ntoumi F
Acta Trop; 2002 Jan; 81(1):33-46. PubMed ID: 11755430
[TBL] [Abstract][Full Text] [Related]
40. Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit.
Valderrama-Aguirre A; Quintero G; Gómez A; Castellanos A; Pérez Y; Méndez F; Arévalo-Herrera M; Herrera S
Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):16-24. PubMed ID: 16291762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
